All Articles
French ALK Study Helps Illuminate the High Negative Dollar Impact of Single Test Strategies With Companion Diagnostics

French ALK Study Helps Illuminate the High Negative Dollar Impact of Single Test Strategies With Companion Diagnostics

24 February, 2014

Jordan Clark and Peter Keeling of Diaceutics critique a journal article exploring the effectiveness of parallel FISH and IHC methods for the detection of ALK. They go on to discuss the financial implications for pharma companies if they do not engage with laboratories before they launch their targeted therapy.|Jordan Clark and Peter Keeling of Diaceutics critique a journal article exploring the effectiveness of parallel FISH and IHC methods for the detection of ALK. They go on to discuss the financial implications for pharma companies if they do not engage with laboratories before they launch their targeted therapy.|Jordan Clark and Peter Keeling of Diaceutics critique a journal article exploring the effectiveness of parallel FISH and IHC methods for the detection of ALK. They go on to discuss the financial implications for pharma companies if they do not engage with laboratories before they launch their targeted therapy.|Jordan Clark and Peter Keeling of Diaceutics critique a journal article exploring the effectiveness of parallel FISH and IHC methods for the detection of ALK. They go on to discuss the financial implications for pharma companies if they do not engage with laboratories before they launch their targeted therapy.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.